Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4788859

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2cc(F)ccc2n1
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL4788859
Phase Preclinical
Structure Type MOL
InChI Key AGMGRCAUAZCHPG-UHFFFAOYSA-N
9
Targets
10
Activities
1
Assay Types
15
PK Parameters
17
Publications
0
Known Names

Molecular Properties

437.5
MW (Da)
5.07
ALogP
5
HBA
1
HBD
45.5
PSA (Ų)
0.43
QED
1
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Unknown
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C27H24FN5
MW 437.52
Aromatic Rings 5
Heavy Atoms 33
NP-Likeness -1.33

Activity Summary

IC50 10 meas. best 8.25

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
 IC50 8.25 6.56 5.6 2
Activin receptor type-1
CHEMBL5903
 IC50 7.96 7.96 10.9 1
Bone morphogenetic protein receptor type-1B
CHEMBL5476
 IC50 7.53 7.53 29.4 1
Activin receptor type-1-like
CHEMBL5311
 IC50 6.78 6.78 166.3 1
Activin receptor type-1B
CHEMBL5310
 IC50 6.25 6.25 568.7 1
TGF-beta receptor type-2
CHEMBL4267
 IC50 6.23 6.23 587.2 1
TGF-beta receptor type-1
CHEMBL4439
 IC50 5.9 5.9 1267.0 1
Platelet-derived growth factor receptor beta
CHEMBL1913
 IC50 5.13 5.13 7450.0 1
Vascular endothelial growth factor receptor 2
CHEMBL279
 IC50 4.87 4.87 13410.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 701.0 ng.hr.mL-1 Rattus norvegicus
AUC 1683.0 ng.hr.mL-1 Rattus norvegicus
CL 12.3 mL.min-1.kg-1 Homo sapiens
CL 7.7 mL.min-1.kg-1 Homo sapiens
CL 207.0 mL.min-1.kg-1 Mus musculus
CL 62.7 mL.min-1.kg-1 Mus musculus
CL 12.9 mL.min-1.kg-1 Rattus norvegicus
Cmax 329.13 nM Rattus norvegicus
Cmax 372.55 nM Rattus norvegicus
F 40.0 % Rattus norvegicus
Fu 0.01 - Homo sapiens
Fu 0.01 - Mus musculus
T1/2 5.9 hr Rattus norvegicus
T1/2 3.9 hr Rattus norvegicus
Tmax 4.0 hr Rattus norvegicus

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 5.6 nM 8.25 Inhibition of human ALK2 R206H mutant using casein as substrate in presence of [... 32750526
Activin receptor type-1 IC50 = 10.9 nM 7.96 Inhibition of human ALK2 using casein as substrate by [gamma-33P]-ATP assay 32750526
Bone morphogenetic protein receptor type-1B IC50 = 29.4 nM 7.53 Inhibition of human ALK6 using casein as substrate by [gamma-33P]-ATP assay 32750526
Activin receptor type-1-like IC50 = 166.3 nM 6.78 Inhibition of human ALK1 using casein as substrate by [gamma-33P]-ATP assay 32750526
Activin receptor type-1B IC50 = 568.7 nM 6.25 Inhibition of human ALK4 using casein as substrate by [gamma-33P]-ATP assay 32750526
TGF-beta receptor type-2 IC50 = 587.2 nM 6.23 Inhibition of human TGFBR2 using MBP as substrate by [gamma-33P]-ATP assay 32750526
TGF-beta receptor type-1 IC50 = 1267.0 nM 5.9 Inhibition of human ALK5 using casein as substrate by [gamma-33P]-ATP assay 32750526
Platelet-derived growth factor receptor beta IC50 = 7450.0 nM 5.13 Inhibition of human PDGFRbeta using poly[Glu:Tyr] (4:1) as substrate by [gamma-3... 32750526
Unchecked IC50 = 13590.0 nM 4.87 Inhibition of recombinant full-length human AMPK using AMARAASAAALARRR as substr... 32750526
Vascular endothelial growth factor receptor 2 IC50 = 13410.0 nM 4.87 Inhibition of human KDR using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-AT... 32750526

Literature References

PubMed DOI Target Context # Activities
32750526 10.1016/j.bmcl.2020.127418 ADMET 19
32750526 10.1016/j.bmcl.2020.127418 Unchecked 2
32750526 10.1016/j.bmcl.2020.127418 Cytochrome P450 2C19 1
32750526 10.1016/j.bmcl.2020.127418 Activin receptor type-1 1
32750526 10.1016/j.bmcl.2020.127418 Cytochrome P450 2C9 1
32750526 10.1016/j.bmcl.2020.127418 Cytochrome P450 2D6 1
32750526 10.1016/j.bmcl.2020.127418 Cytochrome P450 3A4 1
32750526 10.1016/j.bmcl.2020.127418 Cytochrome P450 1A2 1
32750526 10.1016/j.bmcl.2020.127418 Platelet-derived growth factor receptor beta 1
32750526 10.1016/j.bmcl.2020.127418 Vascular endothelial growth factor receptor 2 1
32750526 10.1016/j.bmcl.2020.127418 TGF-beta receptor type-2 1
32750526 10.1016/j.bmcl.2020.127418 Bone morphogenetic protein receptor type-2 1
32750526 10.1016/j.bmcl.2020.127418 Bone morphogenetic protein receptor type-1B 1
32750526 10.1016/j.bmcl.2020.127418 TGF-beta receptor type-1 1
32750526 10.1016/j.bmcl.2020.127418 Activin receptor type-1B 1
32750526 10.1016/j.bmcl.2020.127418 Bone morphogenetic protein receptor type-1A 1
32750526 10.1016/j.bmcl.2020.127418 Activin receptor type-1-like 1

Data from ChEMBL 36 via Core Engine